1. CAR-Ts redirected against the Thomsen-Friedenreich antigen CD176 mediate specific elimination of malignant cells from leukemia and solid tumors
    Anna Christina Dragon et al, 2023, Frontiers in Immunology CrossRef
  2. Coagulation FXIII-A Protein Expression Defines Three Novel Sub-populations in Pediatric B-Cell Progenitor Acute Lymphoblastic Leukemia Characterized by Distinct Gene Expression Signatures
    Katalin Gyurina et al, 2019, Frontiers in Oncology CrossRef
  3. Complementary Methods for de Novo Monoclonal Antibody Sequencing to Achieve Complete Sequence Coverage
    Jianhui Cheng et al, 2020, Journal of Proteome Research CrossRef
  4. Profiling of Naturally Occurring Antibodies to the Thomsen-Friedenreich Antigen in Health and Cancer: The Diversity and Clinical Potential
    Oleg Kurtenkov, 2020, BioMed Research International CrossRef
  5. Sclerotium rolfsii lectin induces opposite effects on normal PBMCs and leukemic Molt-4 cells by recognising TF antigen and its variants as receptors
    Vishwanath B. Chachadi et al, 2020, Glycoconjugate Journal CrossRef

  6. The Potential Action of Thomsen–Friedenreich Monoclonal Antibody (A78-G/A7) in Thyroid Cancer


    Ying Peng et al, 2020, OncoTargets and Therapy CrossRef
  7. Targeting cancer-associated glycans as a therapeutic strategy in leukemia
    Ashraf Abdullah Saad, 2022, All Life CrossRef
  8. The Prognosis of Cancer Depends on the Interplay of Autophagy, Apoptosis, and Anoikis within the Tumor Microenvironment
    Shweta Gulia et al, 2023, Cell Biochemistry and Biophysics CrossRef